Pembroke Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-211,779
Closed -$9.57M 66
2020
Q2
$9.57M Buy
211,779
+16,461
+8% +$738K 1.13% 39
2020
Q1
$7.52M Sell
195,318
-356,653
-65% -$16.4M 1.19% 41
2019
Q4
$25.6M Buy
551,971
+145,371
+36% +$6.3M 2.17% 9
2019
Q3
$16.6M Buy
406,600
+72,219
+22% +$3.12M 1.8% 28
2019
Q2
$16.1M Buy
334,381
+146,181
+78% +$7.68M 1.7% 31
2019
Q1
$11.8M Sell
188,200
-3,100
-2% -$213K 1.27% 38
2018
Q4
$11.4M Sell
191,300
-109,650
-36% -$6.58M 1.56% 30
2018
Q3
$19.4M Sell
300,950
-175,750
-37% -$9.81M 1.99% 24
2018
Q2
$21.5M Sell
476,700
-15,300
-3% -$610K 2.19% 18
2018
Q1
$15.3M Sell
492,000
-42,900
-8% -$1.41M 1.62% 30
2017
Q4
$16M Buy
534,900
+85,600
+19% +$2.48M 1.64% 28
2017
Q3
$14.8M Buy
449,300
+175,200
+64% +$6.07M 1.45% 34
2017
Q2
$9.17M Buy
+274,100
New +$8.18M 0.82% 54

Other funds holding BEAT

Pembroke Management's BEAT Position: Q3 2020 in Review

Pembroke Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 211,779 shares — an estimated $9.57M sold.

Pembroke Management first reported a position in BEAT in Q2 2017 and held it in 13 quarters. The position peaked at $25.6M in Q4 2019. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

  • Pembroke Management reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
  • Pembroke Management sold 211,779 BioTelemetry, Inc. shares in Q3 2020, an estimated $9.57M.
  • Pembroke Management first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 13 quarters.
  • Pembroke Management's BioTelemetry, Inc. position peaked at $25.6M in Q4 2019.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Pembroke Management's 13F filing for Q3 2020, filed 4 Nov 2020.